Sponsored by Intact Vascular
Toba II portal banner

Tack Endovascular System (6F) is FDA approved for SFA and proximal popliteal (3.5-6.0mm RVD) treatment of post-PTA dissections.

Download PDF


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

The TOBA II clinical study was designed to investigate the safety and efficacy of the Tack Endovascular System® in the repair of post-angioplasty dissections in the femoropopliteal arteries. Dr. William A. Gray (TOBA II National Principal Investigator, System Chief of Cardiovascular Services at Main Line Health and President of Lankenau Heart Institute) presents the twelve-month data from this study.

TOBA Clinical Studies Program

Download PDF

Follow @intactvascular


Learn More at intactvascular.com